Skip to main content
. 2023 Oct 23;31(1):614–621. doi: 10.1245/s10434-023-14422-2

Table 3.

Follow-up and recurrence details

Initial treatment (n = 387) Recurrent disease (n = 50) p value
Time to last follow-up (months; median, IQR) 51 (26–90) 35 (19–62) 0.01
Recurrence (n, %) 192 (50%) 28 (56%) 0.45

Bold indicates statistically significant finding